Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension11See Editorial by Noris and Remuzzi, p. 1545.
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 61 (4) , 1462-1468
- https://doi.org/10.1046/j.1523-1755.2002.00260.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patientsJournal of Human Hypertension, 1999
- The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertensionJournal Of Hypertension, 1999
- Angiotensin-Converting Enzyme Inhibition, But Not Calcium Antagonism, Improves a Response of the Renal Vasculature to l -Arginine in Patients With Essential HypertensionHypertension, 1998
- Angiotensin II Blockade Does Not Prevent Renal Effects of L-NAME in Sodium-Repleted HumansHypertension, 1997
- Renal Hemodynamic Response to an Angiotensin II Antagonist, Eprosartan, in Healthy MenHypertension, 1997
- The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.Journal of Clinical Investigation, 1997
- ACE Inhibition, Endothelial Function and Coronary Artery LesionsDrugs, 1997
- Contrasting Effect of Antihypertensive Treatment on the Renal Response to l -ArginineHypertension, 1995
- Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study.BMJ, 1987
- THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN 1Journal of Clinical Investigation, 1945